CFMG & Wellpath in California — a documentary investigation · Article 010 of 100 · Series 1 — Corporate history and the making of an enterprise

The 2026 California Stack: CFMG, Wellpath Operations, Enterprise Clinical Leadership, Zenova, and the County

Published

20 September 2026, 6:00 PM PT

Content last changed

25 September 2026

Public-evidence cutoff

25 September 2026

Sources checked

25 September 2026

Record through

25 September 2026

Editorial status

Public-source editorial review complete

Evidence note. This article relies on public records and distinguishes established fact, party position, allegation, judicial finding, inference and unresolved question. Nothing here is a finding that any identified corporation or individual violated California law unless a cited adjudicative source expressly says so.

Opening frame#

The 2026 California Stack: CFMG, Wellpath Operations, Enterprise Clinical Leadership, Zenova, and the County is fundamentally an identity-and-continuity inquiry. The legal entity, the management platform, the public brand, and the county-facing operation may overlap without becoming interchangeable. The analysis therefore asks what changed, what persisted, and which primary records are capable of proving each proposition.

The governing question is narrow: What does the current multi-layer system look like when each actor is separated by function? The article connects that question to juridical identity, operational integration, professional authority, ownership and succession, practical exit rights, and demonstrated veto power only where the evidence makes those connections material.

I. The Question and the Public Record#

The relevant public record is best read cumulatively. No single branding statement, county agenda item, corporate filing, bankruptcy disclosure, or management agreement resolves the entire relationship. The evidentiary value comes from comparing documents created for different purposes and asking whether they converge on the same allocation of identity, authority, economics, and professional responsibility.

Wellpath now publicly describes CFMG as a physician-owned affiliate#

In March 2026, Wellpath announced a new California-focused operating division called Local Government-California . In the same release, Wellpath called CFMG a Wellpath affiliate and stated in a footnote that CFMG is a professional corporation owned by licensed physicians and affiliated with Wellpath’s management-services organization. Wellpath also described the use of enterprise data infrastructure across its affiliates. Source: Wellpath, Mar. 13, 2026

That is the company’s current public description of the relationship. It is useful evidence of how Wellpath describes the architecture; it is not independent proof of the identity of CFMG’s individual shareholders or of how professional authority functions in every decision.

Employment-control cluster#

Overfield — one of the strongest public physician-employment cases. The record treats the physician as a CFMG employee while enterprise-associated HR personnel supply corporate testimony concerning termination. The current public record does not establish that the termination arose from clinical judgment; contrary testimony matters.

Vizgaudis-Gomez — separate CFMG/Wellpath defendants in an employment setting; high potential but do not infer joint employment before the Mendoza declaration and merits record are reviewed.

Wagner and related Nevada County records — useful for workforce and program allocation rather than automatic CPOM conclusions.

Enterprise quality system#

The reviewed public litigation establishes a substantive enterprise clinical-quality system, including:

• Clinical Mortality Review;

• Administrative Mortality Review;

• Part III / Form 01c;

• local RHA/HSA drafting;

• Wellpath Corporate Office receipt;

• Patient Safety Committee;

• CQI / Quality Innovations;

• PSES;

• external PSO reporting;

• County/client participation;

• root-cause analysis;

• improvement planning.

This defeats the early simplistic model “CFMG = clinical, Wellpath = only administrative.”

MSA continuity#

The Plan uses a broad assumption mechanism for executory contracts not rejected or otherwise treated. The CFMG MSA was filed in the bankruptcy. Targeted review has not found CFMG on the first rejection schedule, and post-emergence operations strongly support continuity. A later El Dorado administrative-expense filing states that debtor-side obligations connected with a CFMG medical-services contract were assumed. Exact final confirmation still requires all rejection schedules and any post-emergence amendment/ratification.

II. Structural and Historical Context#

What the timeline does not answer#

The corporate history tells us who appeared where.

It does not yet answer:

• who owned CFMG shares during every period;

• what rights were contained in the CFMG-specific stock-transfer restriction agreements;

• whether CFMG could replace Wellpath as manager without significant contractual consequences;

• how formal physician authority operated in practice;

• or which entity had the last word in a disputed physician-reserved decision.

Those are subjects for the management-architecture, litigation and authority-map pages.

Quality-control cluster#

Hultman — substantive Wellpath Clinical Mortality Review, Administrative Mortality Review, Patient Safety Committee, root-cause analysis, and improvement planning.

K.C. — local RHA/HSA → Wellpath Corporate Office quality workflow, CQI hierarchy, Part III/Form 01c, client participation, PSES/PSO evidence, and the 2023 policy-review breakpoint.

Kartchner — CFMG withholds/controls Part III in discovery and asserts PSQIA protections; court orders production. Strong evidence of CFMG institutional quality role plus Wellpath enterprise architecture.

Johnson/Shasta — unusually rich historical set connecting CFMG finances, policies, staffing, corrective action, mortality review, and Raymond Herr.

III. The Control and Governance Analysis#

Why California law makes that distinction important#

The Medical Board of California says the state’s corporate-practice doctrine is intended to prevent unlicensed persons from interfering with physician professional judgment. Its current guidance identifies decisions such as diagnostic testing, referrals, ultimate patient care, physician workload and hours, clinically related hiring or firing, medical-record control, coding and billing, and medical-equipment decisions as areas in which physician authority matters. The Board says an MSO may be consulted, but the licensed physician must retain ultimate responsibility or approval for decisions that cannot be delegated. Source: Medical Board of California

That does not mean a large MSO is inherently unlawful.

It means the boundary matters .

The “last word” test#

The Medical Board’s guidance says that while physicians may consult unlicensed persons regarding relevant management decisions, the physician must retain ultimate responsibility or approval for the decisions that cannot be delegated.

That gives this investigation a practical test.

For any disputed function, ask:

• Who identified the issue?

• Who gathered the information?

• Who made the recommendation?

• Did a licensed physician independently review it?

• Who had authority to approve, reject or modify the recommendation?

• Who implemented the result?

• What happened when management and physician leadership disagreed?

The identity of the person who sends the email or changes the computer status may not answer the question.

The legally important actor may be the person who possessed the final veto.

Inside the CFMG–Wellpath Management Architecture#

The 2012 CFMG Management Services Agreement is unusually revealing. It formally reserves professional medicine to CFMG while assigning the management company a wide operating role across employment, finance, records, information systems, insurance, claims and other administrative functions. The contract therefore supports both professional separation and deep operational integration.

Many discussions of management-services organizations fail because they start with a conclusion.

Either the MSO is described as a routine back-office vendor, or its broad involvement is treated as proof that it controls the medical practice.

CFMG’s publicly filed management agreement makes both shortcuts difficult.

The contract contains unusually explicit language protecting physician authority.

It also gives the manager unusually broad responsibilities.

The document is therefore best read as an authority map .

Layer two: an exclusive management relationship#

The agreement makes the management company CFMG’s exclusive provider of management services .

The manager is authorized to perform those services in the manner it considers reasonably appropriate to meet the day-to-day business needs of CFMG, subject to the agreement and applicable law.

This is not a narrow payroll contract.

Exhibit B describes a broad operating platform.

Among the functions assigned to the manager are categories involving:

• legal and regulatory support;

• accounting and finance;

• payroll and tax administration;

• benefit-plan administration;

• administrative personnel;

• information technology;

• database and connectivity services;

• electronic medical-record implementation and maintenance;

• insurance and risk management;

• billing and collections;

• record-maintenance infrastructure;

• supplies and support services;

• purchasing;

• marketing and bidding assistance;

• and office support.

The correct conclusion is straightforward:

The contract contemplated extensive administrative integration from the beginning.

That does not answer who had final professional authority.

Layer three: the Company Designee#

One of the most important governance provisions appears early in the agreement.

When the contract calls for CFMG approval, consent, direction or other action — unless the agreement says otherwise — action by the person designated as CFMG’s chief executive officer under its bylaws, termed the Company Designee , can constitute action by CFMG.

The agreement also provides for a management-company representative to attend and participate in certain meetings involving the Company Designee and equityholders, in a non-voting capacity.

This is a governance-adjacent mechanism.

It proves that the management relationship reached beyond isolated back-office tasks.

It does not prove that the manager had a vote or could compel a professional decision.

The public investigation therefore needs to identify:

• who served as Company Designee over time;

• what authority CFMG’s bylaws gave that role;

• and what categories of decisions moved through that approval channel.

Layer four: physician staffing — recommendation versus final decision#

The agreement creates a useful natural test of authority.

It says the management company will periodically review and make recommendations regarding the appropriate number of physicians needed to operate the practice sites.

But it also says final determinations concerning physician staffing levels are the responsibility of CFMG.

That division can be written as:

Wellpath/manager: review + recommend

CFMG: final determination

This is exactly the kind of allocation that should be tested in public records.

Routine agreement between the two actors tells us little.

A disagreement would tell us much more.

If a management recommendation was rejected or modified by CFMG and the CFMG decision was implemented, that would be strong evidence of practical professional veto.

If the opposite occurred, it would raise a different question.

At present, the public contract establishes the formal allocation. Later pages will search for implementation evidence.

Layer seven: finance and cash management#

The agreement also creates substantial financial integration.

The management-services package includes:

• accounting;

• financial reporting;

• invoicing;

• payroll/tax support;

• budgeting;

• cash management;

• benefit and bonus-plan administration.

Exhibit D provides for a management fee calculated as a percentage of adjusted gross revenues — identified in the filed version as 18% — and states that the parties regarded the fee as fair-market-value compensation for management services.

The same exhibit authorizes specified disbursement mechanics and grants the management company a security interest in CFMG assets to the extent permitted by law, with references to broader credit arrangements.

These are economically important provisions.

They are not, by themselves, proof of professional control.

But they make separate questions worth investigating:

• How economically dependent was CFMG on the management structure?

• What happened if the management agreement ended?

• What did the referenced deficit-funding and credit documents provide?

• Could financial remedies affect the practical ability to change managers?

Those questions require the related contracts, not inference from the MSA alone.

Layer twelve: the current Wellpath description#

Wellpath’s March 2026 California operating-division announcement provides a useful modern cross-check.

Wellpath publicly calls CFMG:

• a Wellpath affiliate;

• a professional corporation;

• owned by licensed physicians;

• affiliated with Wellpath’s MSO.

It also describes California operations as leveraging enterprise data infrastructure across Wellpath affiliates. Wellpath, Mar. 13, 2026

That description is consistent with the broad architecture reflected in the older MSA:

professional corporation + management platform .

The remaining question is how that architecture functions in practice.

It does not prove#

• that every formal safeguard was followed in practice;

• that the management company actually overrode CFMG physicians;

• that CFMG exercised an independent veto in every relevant event;

• that Wellpath owned CFMG professional-corporation shares;

• what the stock-transfer restrictions actually provided;

• or that the structure violated California law.

Those conclusions require evidence beyond the contract.

Zenova#

Zenova Management, LLC and Zenova Telehealth, LLC appear in the Wellpath bankruptcy group. Zenova Physicians, P.C. appears separately in professional-corporation contexts. Current Zenova materials describe virtual clinical services. CFMG/Wellpath proposals increasingly incorporate Zenova, and Bazzel has appeared using a Zenova email domain in CFMG contract-related records. This establishes a legitimate current affiliation/service-delivery inquiry, not Zenova ownership or control of CFMG.

Four/five-layer authority model#

Fresno contains at least:

• County / Sheriff / Hall — facility access, security, custody, contract oversight, remedial obligations, some staffing/service requirements.

• CFMG — formal professional corporation, County contractor, substantial formal employer evidence, claimed physician-governance authority.

• Wellpath / Local Government–California / enterprise operations — HR, payroll administration, credentialing administration, IT/access, claims, defense, enterprise records and policy systems.

• Enterprise clinical leadership — quality, patient-safety, clinical programs, physician executives.

• Individual clinicians — patient-specific diagnosis, treatment, referral, escalation, documentation.

A sixth platform layer may exist where Zenova or another affiliate supplies service-line care.

Current contract continuity#

Fresno's formal jail-health agreement continues in CFMG's name through major amendments. Amendment XII, approved December 3, 2024, extended the agreement through June 30, 2029 with optional years. Amendment XIII (County File 26-0855) adds CalAIM Justice-Involved prerelease services and raises the cumulative ceiling by $6,104,438 to $400,479,492. The post–September 22, 2026 County record assigns it Agreement No. 26-459 and Resolution No. 26-329 and lists a Digital Signature Certificate among the filed materials. The Legistar page's “Final action” field remains blank, so this investigation does not characterize Board approval as conclusively recorded from that page alone.

This is powerful current evidence of CFMG juridical continuity after bankruptcy and after creation of Local Government–California.

The 2026 stack in one Fresno record#

The post–September 22, 2026 Fresno County legislative record materially sharpens the CFMG–Wellpath allocation-of-function analysis. County File 26-0855 now assigns the transaction Agreement No. 26-459 and Resolution No. 26-329 and lists a Digital Signature Certificate among the filed materials. The Legistar page's “Final action” field nevertheless remains blank. This investigation therefore does not characterize Board approval as conclusively recorded from that page alone.

A divisional reorganization inside the management organization does not by itself alter CFMG's professional control. This Fresno record allocates operating, billing and coordination functions; it is silent on physician-reserved clinical judgment. See Article 031.

Sonoma — clearest current PC/MSO recital#

Sonoma's 2026 MAT agreement is among the strongest current documents because it names CFMG as contractor and separately identifies Wellpath LLC as the Management Services Organization providing functions such as accounting, regulatory support, claims/litigation assistance, payroll, invoicing, risk management, and HR. The same contract separately gives the County powers over staffing, audits, security, and removal of assigned personnel.

This is a clean example of distributed authority , not one actor controlling everything.

Program allocation is itself a control question#

Across counties, JBCT and related services appear under different entities. This raises questions about who decides:

• which PC carries a program;

• which entity employs staff;

• how workers transfer when a program moves;

• which PC holds clinical responsibility;

• whether enterprise economics or professional governance drives the allocation.

No general conclusion should be drawn without program-specific contracts.

National vertical management model — research hypothesis#

A recurring feature of the Wellpath model is national vertical management. Public corporate materials describe a large multi-state enterprise headquartered in Tennessee. Operational records and employment communications in the public record indicate that California functions were frequently administered through Wellpath executives, HR personnel, legal/risk personnel, and clinical leadership outside the local county facilities.

The relevant issue is not geography. A physician executive may lawfully supervise clinicians from another state, and an MSO may lawfully centralize administrative services. The relevant issue is authority .

the record should test the following hypothesis:

CFMG physicians may have held formal professional-corporation offices while substantial day-to-day operational authority flowed vertically through Wellpath's national or regional chain of command, with local jail physicians and healthcare staff reporting through Wellpath-managed operational structures.

This hypothesis must be tested county by county and function by function.

The evidence required includes:

• organizational charts by year;

• reporting lines for physicians, nursing, mental health, pharmacy, and dental services;

• job descriptions for HSA, DON, site medical director, regional medical director, state medical director, chief medical officer, and operations executives;

• authority matrices;

• policy approval metadata;

• EHR access-control records;

• compensation approval chains;

• disciplinary/termination workflows;

• county-facing escalation protocols;

• CFMG board minutes showing actual physician deliberation.

POST-BANKRUPTCY LOCAL GOVERNMENT–CALIFORNIA#

Wellpath’s creation of Local Government–California in 2026 is not merely a branding event.

It creates a new level of organizational hierarchy through which California local-government operations are coordinated.

The announcement:

• identifies Jessica Mazlum as division president;

• describes CFMG as physician-owned;

• places the California operation within the broader Wellpath platform;

• emphasizes shared enterprise resources/data capabilities.

The research question is not whether Mazlum is a physician. A nonphysician can lawfully lead an MSO operating division.

The question is how the new division allocates authority to CFMG’s physician governance.

Required records:

• Local Government–California org chart;

• reporting line from CFMG president/shareholders;

• division president authority matrix;

• California chief clinical/medical leadership;

• who approves physician hiring/termination;

• who signs county bids;

• who approves pricing;

• who owns clinical policies;

• who approves utilization-management rules;

• who controls EHR permissions;

• who can override site medical directors.

The post-bankruptcy reorganization gives the record a natural before/after comparison.

Domain five — clinical policy and national vertical medical leadership#

A national Wellpath physician executive is still a physician. The fact that a clinical leader sits in Tennessee rather than California does not itself create a CPOM problem.

The questions are California licensure, CFMG authority, entity capacity, delegation, and final approval.

In April 2025, Wellpath’s Chief Medical Officer stated in writing that Wellpath was the Management Services Organization contracted to provide the full range of administrative services to CFMG . The same communication said Wellpath had reviewed disputed matters with CFMG leadership and was communicating with the CFMG physician with CFMG leadership’s knowledge and approval.

That evidence supports both sides:

Integration: a national Wellpath chief medical executive functioned as a central interface in a CFMG physician matter.

Potential independence/agency: he expressly represented that Wellpath was acting with CFMG leadership’s knowledge and approval.

Neither statement establishes whether CFMG approval was independent, contemporaneous, and meaningful.

For every enterprise clinical policy, the record should identify:

• who authored it;

• entity employing author;

• California licensure;

• who approved it for CFMG;

• whether CFMG-specific approval exists;

• whether CFMG could reject or modify it;

• whether CFMG ever did so;

• whether treating physicians could depart when clinically necessary.

Current assessment: National Wellpath clinical-leadership involvement is strong; CFMG’s contractual ultimate authority is strong; approval matrices and override evidence are missing.

THE 2026 LOCAL GOVERNMENT–CALIFORNIA DIVISION IS ANOTHER NATURAL EXPERIMENT#

In March 2026 Wellpath announced a new California operating division, Local Government–California, while describing CFMG as a physician-owned professional corporation affiliated with Wellpath's MSO.

The organizational change raises a parallel set of structural questions:

• Did CFMG board/shareholders approve the new division's authority over CFMG-supported contracts?

• Did the MSA change?

• Did compensation or management-fee schedules change?

• Did a new delegation matrix issue?

• Did California leadership obtain authority from CFMG or only from Wellpath?

• Did the Company Designee change?

• Were stock-transfer or governance agreements amended?

A divisional reorganization inside the MSO does not automatically affect CFMG's professional control.

But if practical authority changed, the CFMG corporate record should show how it was authorized.

THE MARCH 2026 LOCAL GOVERNMENT–CALIFORNIA REORGANIZATION CREATES A SECOND GOVERNANCE STRESS TEST#

On March 13, 2026, Wellpath announced creation of a new operating division:

Local Government–California

and appointed Jessica Mazlum as Division President.

Wellpath expressly described CFMG as:

• a Wellpath affiliate;

• a professional corporation;

• owned by licensed physicians;

• affiliated with Wellpath’s management-services organization.

Primary source:

https://wellpathcare.com/2026/03/13/wellpath-announces-creation-of-a-new-operating-division-in-california-appoints-new-highly-experienced-leader/

Wellpath also said the California operation would leverage the company’s enterprise data infrastructure.

This creates a new post-bankruptcy governance question:

What CFMG corporate action authorized the role of the Local Government–California division in the operations supporting CFMG’s California contracts?

Possible answers include:

• no CFMG approval was needed because the division was merely an internal MSO reorganization;

• CFMG approved a delegation;

• the existing MSA already allowed the reorganization;

• or amendments/delegation matrices were executed.

The public announcement does not answer that.

Again, the issue is not whether a nonphysician can lead an MSO division. A nonphysician can.

The question is where her authority ends and CFMG physician authority begins.

The strongest current documentary reconstruction is that the CFMG management relationship did not require a new publicly filed post-bankruptcy assignment to move from the H.I.G.-era enterprise into reorganized Wellpath.

The more likely mechanism is simpler:

Wellpath LLC was already the manager under the January 1, 2019 assignment; it entered Chapter 11 as the contracting debtor; the CFMG MSA was still being described by Wellpath as operative during bankruptcy; the final Plan deemed all executory contracts assumed unless specifically rejected or otherwise excepted; no California Forensic Medical Group / CFMG MSA entry has been located in the reviewed rejection notices or final rejection schedule; the Confirmation Order made those assumptions effective without further court order; and the assumed contract re-vested in the applicable contracting Post-Restructuring Debtor.

That chain makes deemed assumption by Wellpath LLC on the May 9, 2025 Effective Date the best-supported explanation for continuity of the CFMG MSA.

This conclusion rests on five independent documentary points. First, the January 1, 2019 Assignment expressly made Wellpath LLC the “Manager” under the CFMG MSA. Second, as late as February 11, 2025, Wellpath’s own bankruptcy filing described CFMG as a professional corporation to which the Debtors provided managerial services pursuant to the January 2019 CFMG MSA . Third, Article V of the confirmed Plan provides that, on the Effective Date, all executory contracts are deemed assumed by the applicable Post-Restructuring Debtor unless they fall within stated exceptions. Fourth, the final Rejected Executory Contracts Schedule filed April 29, 2025 affirmatively rejects another professional-corporation relationship— Grand Prairie Healthcare PC —while no CFMG / California Forensic Medical Group entry has been located in the searchable final schedule. Fifth, a 2026 Sonoma County professional-services agreement again expressly identifies Wellpath LLC as the Management Services Organization providing administrative services to CFMG .

The conclusion requires one important qualification. The precise Docket 194 schedule row and proposed cure amount for the CFMG MSA have not yet been located in the searchable public corpus, and this investigation has not located any private post-emergence amendment or CFMG board ratification. Accordingly, the statement that the CFMG MSA was deemed assumed is a high-confidence documentary/legal inference , not a substitute for obtaining the exact contract register and cure schedule.

IV. Contrary Evidence, Limits, and Competing Explanations#

A disciplined analysis must begin its limiting case with the strongest contrary evidence: Counterevidence to any simple narrative includes CFMG's continued legal existence, the distinction between enterprise transactions and PC shares, and the fact that later branding can obscure rather than replace juridical identity.

What this legal framework does not prove#

Nothing on this page establishes that:

• Wellpath unlawfully practiced medicine;

• CFMG failed to exercise professional independence;

• a particular management function violated §2400;

• a particular shareholder arrangement was unlawful;

• or a regulator or court has adjudicated the CFMG–Wellpath structure unlawful.

Those are factual and legal conclusions that require CFMG-specific evidence.

The purpose of the framework is to identify what evidence would matter.

DHEERAJ TARANATH is distinct from THE VERIFIED CFMG BOARD#

Dr. Dheeraj Taranath is highly relevant to CFMG operations, but the current evidence does not establish him as a CFMG shareholder, director, or officer.

Wellpath's current leadership page identifies him as:

Chief Clinical Officer, Wellpath

The Wellpath bankruptcy plan likewise listed him among the officers of reorganized Wellpath as Chief Clinical Officer.

County materials in 2026 identify him as a Wellpath chief medical/clinical executive.

He has also communicated on CFMG-related matters.

But those facts do not put him on CFMG's board.

This distinction is important because loose shorthand of the form "physician shareholders and leadership" is easy to apply to any senior clinician associated with the enterprise, including Taranath.

For public publication, that shorthand must not become a factual assertion of share ownership.

The correct description is:

Wellpath Chief Clinical Officer who has participated in CFMG-related clinical/organizational matters; no current public proof of CFMG share ownership or board office identified.

V. Missing Documents and Falsification Tests#

The record remains incomplete in material respects. Key unresolved points include exact corporate succession, historical ownership, and whether later enterprise changes altered only management or also professional-corporation governance.

The structural-control question#

The core structural question is not whether Wellpath legally owned CFMG.

The strongest currently available evidence cuts against that simplistic proposition.

In November 2024, Wellpath board co-chair Kip Hallman publicly stated that CFMG was a wholly separate entity, owned primarily by physicians, with no ownership overlap with Wellpath. Santa Barbara County later described CFMG as a separate physician-owned entity that used Wellpath to manage business aspects. CFMG remained a nondebtor professional corporation during the Wellpath Chapter 11 case.

Those facts are material.

But ownership of stock is only one form of control.

California's 2026 enforcement posture requires examination of whether a nonprofessional enterprise can exercise control through:

• contractual replacement rights;

• shareholder succession mechanisms;

• long-term exclusive management arrangements;

• financing;

• security interests;

• bank-account authority;

• control of assets or infrastructure;

• assignment rights;

• practical inability of the physician corporation to replace the manager.

The central the prior analysis inquiry therefore is:

Could CFMG physician owners independently reject, replace, or terminate Wellpath and continue operating a viable California medical corporation?

VI. Why the Issue Matters#

The stakes are practical rather than semantic. Counties need to know which entity is accountable for contracted performance; clinicians need to know where professional authority resides; courts and regulators need entity-specific evidence rather than brand shorthand; and the public needs a record that distinguishes corporate continuity from operational integration. Those distinctions become most important when the actors disagree, when a contract changes hands, when a professional decision conflicts with an economic preference, or when litigation requires a precise answer to who had authority to act.

POST-BANKRUPTCY CALIFORNIA: LOCAL GOVERNMENT–CALIFORNIA#

In March 2026, Wellpath publicly announced a new Local Government–California operating division led by Jessica Mazlum. Wellpath simultaneously described CFMG as a physician-owned professional corporation affiliated with Wellpath's management-services organization.

This is the clearest current public articulation of the model:

CFMG = physician professional corporation

Wellpath = management-services / operating platform

The new division raises important continuity questions:

• Did the underlying CFMG MSA change after bankruptcy?

• Did ownership or control rights change?

• Did new lenders inherit contractual rights over the MSO that affect CFMG?

• Did CFMG physician ownership change?

• What authority does the Local Government–California president have over California clinical operations?

• What authority remains exclusively with CFMG physicians?

• Who reports to Jessica Mazlum?

• Who reports to CFMG's physician officers?

• Who approves physician employment, workload, compensation, and discipline?

These questions should be tested through 2026 county procurement records and current corporate filings.

VII. Falsification Tests and Evidentiary Limits Note#

The record does not support be read as establishing an unproven motive, an undisclosed shareholder, an unlawful medical override, or a legal conclusion that a court or regulator has not made. The strongest version of the thesis is the one that survives the missing-document test: identify the instrument, minutes, ledger, delegation, approval record, or disagreement event that would materially change the conclusion, then state what has and has not been found. If later primary evidence contradicts a proposition stated here, the correction should be made at the proposition level rather than defended through branding or organizational shorthand.

VIII. Related Articles#

• Article 009 — From Chapter 11 to Local Government–California: The 2026 Reorganization of the Operating Layer

• Article 011 — What the MSA Actually Reserves to Physicians

• Article 008 — The Other 'CFMG': Why Wellpath CFMG, Inc. Is Not Automatically California Forensic Medical Group

A sixth element: the codified standard#

This article maps the 2026 California configuration. Two enacted statutes belong on that map and postdate the original analysis.

Senate Bill 351 and Assembly Bill 1415 were signed in October 2025 and took effect on 1 January 2026, emerging from Assembly Bill 3129 after the legislature split it. SB 351 codifies the corporate-practice-of-medicine prohibition; AB 1415 extends Office of Health Care Affordability reporting to private-equity groups and management-services organizations.

A third element is corporate. In March 2026 Wellpath announced a new California operating division with new leadership — an internal management structure rather than a legal entity, and not an assertion of any change in professional-corporation ownership. It belongs on the map because the stack this article describes is one of operating structures as much as legal entities, and a California-specific division is a new operating layer.

What the statutes change is the environment rather than the stack. Every relationship on this map between the management organization and a California professional corporation is, from January 2026, measured against an enacted standard rather than an assembled doctrine, and transactions of the kind that built the stack now carry reporting obligations they did not carry when the stack was assembled.

The limits are ordinary. Both statutes run prospectively and do not reach the arrangements this article describes. Codification supplies a standard, not a finding. And no public enforcement action concerning any entity on this map has been located.

IX. The 2026 California stack should be drawn as a function map#

The current California structure is best understood as a stack of overlapping authority rather than a conventional single-company org chart. At minimum, the public record identifies a county-government layer, a professional-corporation layer, a Wellpath management and operating layer, an enterprise clinical layer, specialized professional or telehealth entities, and individual licensed clinicians. Each can possess real authority without possessing all authority.

The county layer controls procurement, custody conditions, contract scope, funding, performance requirements, access, and remedies for contract default. Those powers can materially shape healthcare delivery, but they do not ordinarily convert county administrators into treating physicians. The professional-corporation layer supplies the legal vehicle for professional medical services and, under the stated contractual model, retains physician-reserved authority. The Wellpath operating layer supplies the administrative platform and, after the 2026 reorganization, a California-specific management structure. Enterprise clinical leadership can develop programs, quality systems, and clinical frameworks across the platform. Specialized entities may provide discrete services such as telehealth. Individual physicians remain personally subject to licensure and professional duties.

The danger is to mistake visibility for legal primacy. A division president may be the most visible operational executive while lacking authority to decide a physician-reserved matter. A chief clinical officer may influence policy across the enterprise without holding CFMG corporate office. A CFMG officer may possess formal professional authority while relying on Wellpath staff to implement the decision. The proper question is therefore not “who is in charge?” but “who was in charge of this function, at this time, under what source of authority?”

The six-column authority matrix#

A serious brief should use six columns for disputed decisions: function; initiating actor; recommending actor; formal decision-maker; implementing actor; reviewing or vetoing authority. Applying that matrix can prevent several recurrent errors.

For staffing, the county may set minimum service levels, Wellpath may recruit and model costs, CFMG may possess final physician-staffing authority under the MSA, and facility security may still control physical access. For clinical policy, enterprise clinical leaders may draft or recommend a policy, but the question is whether CFMG or an authorized physician body adopted it before implementation in California. For employment, HR may administer the process while the legal employer or professional body retains specified decision rights. For claims, Wellpath may coordinate defense even when the underlying employer or contractor was CFMG.

This matrix also makes contradictions more manageable. Two documents can both be accurate if they describe different columns. A county record calling Wellpath the healthcare provider may describe the operating brand. An NLRB record naming CFMG as employer may answer a labor-law question. A corporate announcement may describe affiliation. None should automatically erase the others.

Current leadership must be analyzed by capacity#

The 2026 operating structure makes leadership capacity especially important. Jessica Mazlum's California operating role and Dheeraj Taranath's enterprise clinical role are evidence of substantial Wellpath authority, but public titles do not by themselves establish CFMG share ownership or final authority over all physician-reserved decisions. The same caution applies to CFMG physician officers: a title proves office only for the period and capacity supported by the record.

The most probative future records are delegation matrices, committee charters, policy-signature pages, board minutes, appointment resolutions, and actual conflict records. If those documents show that Wellpath leaders can propose but CFMG must approve—and that CFMG has actually rejected proposals—formal independence becomes more concrete. If they show implementation before CFMG approval or no meaningful ability to reject, the practical-control concern grows.

Bottom-line architecture#

The 2026 California stack is therefore neither a single corporation nor a set of strangers. It is an integrated network whose legality and accountability must be evaluated function by function. That is a more demanding framework than brand attribution, but it is also the only framework capable of explaining why county contracts, employment records, bankruptcy filings, and corporate announcements can use different names without necessarily contradicting one another.

X. Conflict analysis: which layer wins when duties point in different directions?#

A layered system is easiest to understand in ordinary operations, when everyone agrees. The real governance test arises when two legitimate sources of authority point in different directions. Suppose a county contract requires a staffing level, the manager identifies a budget constraint, and CFMG physicians conclude that a higher level is clinically necessary. The important evidence is not the org chart; it is the escalation pathway and the final implemented decision. The same is true if a security restriction conflicts with a clinician's access recommendation, or if an enterprise clinical initiative conflicts with a CFMG professional judgment.

The analysis therefore must identify conflict jurisdiction for each layer. Counties can enforce the contract and control the jail environment. The MSO can exercise contractual management rights. CFMG can exercise professional-corporation rights reserved by law and contract. Individual clinicians must comply with licensure duties. Courts can impose remedial requirements. When those authorities conflict, the record should show whether the issue was escalated to the correct decision-maker or resolved by the most operationally powerful actor regardless of legal capacity.

Implementation power is a distinct source of influence#

Even when another entity possesses final formal authority, the organization that controls implementation can wield substantial practical influence. IT access, payroll, scheduling, procurement, credentialing workflow, and county communications can determine whether a decision becomes real. Implementation authority therefore belongs in the control map, but it should not be confused with the legal authority to decide.

A strong lawful record would show that Wellpath implementation systems execute CFMG professional decisions once approved, including decisions the management side opposed. A concerning record would show that implementation can be withheld or altered unless the professional body accepts the manager's preferred outcome. Again, the key evidence is conflict-tested conduct, not routine cooperation.

The six-layer map thus becomes a litigation tool. It allows counsel to ask a witness not merely “who supervised you?” but “who could initiate, decide, block, implement, and review this specific action?” That question is capable of producing a legally useful answer in a way that “Was Wellpath in control?” is not.

The stack should produce auditable signatures#

A real authority stack leaves documentary signatures. County authority appears in contracts, amendments, notices, audits, and access rules. CFMG authority should appear in board resolutions, professional approvals, physician employment actions, credentialing records, and policy adoption. Wellpath management authority should appear in budgets, HR workflows, service agreements, operational directives, technology administration, and claims systems. Enterprise clinical influence should appear in program materials, quality structures, and recommendations. Individual professional judgment appears in patient-specific decisions and licensed duties.

When the signatures align, attribution becomes easier. When they do not, the discrepancy is the story. A county may describe Wellpath as provider while the executed contract names CFMG. A Wellpath executive may announce a program while a CFMG physician body formally adopts it. Those facts are not mutually exclusive; they describe different layers.

The analysis therefore must include an instruction for every later author: before writing that an entity “controlled” something, identify the documentary signature of initiation, formal authority, and implementation. If one of those is missing, use a narrower verb. This is the difference between an investigative conclusion that can survive cross-examination and a brand-based impression.

Conclusion#

Article 010 should be published only at the level of confidence the record supports. The controlling proposition is the one stated in the question presented above; adjacent issues such as ownership, employer status, professional authority, bankruptcy treatment, and branding should remain separate unless a primary source supplies the bridge. The strongest contrary evidence belongs in the article, not in an editorial footnote, and any unresolved ownership, delegation, succession, or decision-chain record should remain identified as a document target rather than converted into a factual assertion.

Sources and authorities#

1. Source: Wellpath, Mar. 13, 2026 wellpathcare.com — https://wellpathcare.com/2026/03/13/wellpath-announces-creation-of-a-new-operating-division-in-california-appoints-new-highly-experienced-leader/
2. Source: Medical Board of California www.mbc.ca.gov — https://www.mbc.ca.gov/Licensing/Physicians-and-Surgeons/Practice-Information/

The stack as the courts now sort it#

The most current judicial treatment of the California stack came on September 15, 2026, in Estate of Jeremiah Wright v. County of Stanislaus, E.D. Cal. No. 2:24-cv-02505. Three of the layers this article maps — CFMG, Wellpath LLC and Wellpath Management, Inc. — moved jointly to dismiss, and the court sorted them by their actual procedural and bankruptcy status rather than by brand.

Wellpath LLC was dismissed as a discharged Chapter 11 debtor, the court finding that plaintiffs could fairly have contemplated claims against it before the Plan's May 9, 2025 effective date. Wellpath Management, Inc., also a debtor, was not dismissed: defendants had not shown from the pleadings that plaintiffs had reason before confirmation to attribute the alleged conduct to that entity specifically. CFMG, a nondebtor, remained in the case.

For a 2026 stack analysis the order is significant in two ways. It confirms that the layers are legally distinct in the one setting where distinctness is most consequential — discharge — and it shows that even the two debtor layers are not interchangeable. Discharge attached to Wellpath LLC and not to Wellpath Management on the same facts, because the test turned on what the claimant could have known about each entity's involvement, not on the enterprise's corporate family.

The order also preserves the original 2024 pleading, which named "California Forensic Medical Group, Inc. dba Wellpath LLC" — a single collapsed label for what the court ultimately treated as three defendants with three outcomes. That progression, from operating name to entity-specific adjudication, is the stack this article describes being forced into legal precision by a federal court.

What the order does not do is decide how the layers relate. It did not find joint employment, alter ego, shared clinical control or single-enterprise status. It decided which entities remained suable. The stack's internal authority relationships — who decides what, for whom — remain the open question this series carries forward.